BP
IDXX icon

BNP Paribas’s Idexx Laboratories IDXX Stock Holding History

BNP Paribas’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.9K Sell
96
-169
-64% -$108K ﹤0.01% 264
2025
Q4 		$180K Buy
+265
New +$180K 0.01% 242
2024
Q4 		– Sell
-1,911
Closed -$968K – 395
2024
Q3 		$968K Buy
1,911
+5
+0.3% +$2.43K 0.04% 162
2024
Q2 		$932K Hold
1,906
– – 0.05% 155
2024
Q1 		$1.03M Buy
+1,906
New +$1.04M 0.05% 166

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas's IDXX Position: Q1 2026 in Review

BNP Paribas reduced its Idexx Laboratories (IDXX) stake by 64% in Q1 2026, selling an estimated $108K and leaving 96 shares worth $53.9K. The position accounts for ﹤0.01% of the portfolio, ranked #264.

BNP Paribas first reported a position in IDXX in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.03M in Q1 2024. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • BNP Paribas held 96 shares of Idexx Laboratories worth $53.9K as of Q1 2026.
  • BNP Paribas sold 169 Idexx Laboratories shares in Q1 2026, an estimated $108K.
  • Idexx Laboratories made up ﹤0.01% of BNP Paribas's portfolio in Q1 2026, its #264 holding.
  • BNP Paribas first reported a position in Idexx Laboratories in Q1 2024 and has held it in 5 quarters since.
  • BNP Paribas's Idexx Laboratories position peaked at $1.03M in Q1 2024.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.